Results 121 to 130 of about 105,810 (209)

[Triglyceride-glucose index changes after one year of antiretroviral therapy]. [PDF]

Rev Med Inst Mex Seguro Soc
Pérez-Pedraza EE, Albarrán-Sánchez A, Ramírez-Rentería C.   +2 more
europepmc   +1 more source

[Management of type 2 diabetes mellitus in frail patients from the Perspective of Real-World Clinical Practice]. [PDF]

Aten Primaria
Miñana-Castellanos M, Ramon Granés M, Fernández Camins B, Navas Méndez E, Barrot de la Puente J, Lapena Estella C.   +5 more
europepmc   +1 more source

[Comprehensive care of patients with type 1 diabetes in primary health care: policies, practices, and the role of civil societyAtenção integral a pacientes com diabetes tipo 1 na atenção primária à saúde: políticas, práticas e o papel da sociedade civil]. [PDF]

Rev Panam Salud Publica
Rangel-Osuna F, Infante-Xibillé C, Orozco-Núñez E.   +2 more
europepmc   +1 more source

Middle-range theory of the risk for ineffective glucose pattern self-management in hemodialysis. [PDF]

Rev Bras Enferm
Ferreira LL, Martins CCG, Nunes LHS, Araújo AFL, Fernandes MIDCD, Lira ALBC.   +5 more
europepmc   +1 more source

[Comments on the article "Main factors associated with hypoglycemia in patients with type 2 diabetes"]. [PDF]

Rev Med Inst Mex Seguro Soc
Calleja-Alarcón S, Sánchez-Hurtado LA, Rivas-Ruiz R, Romero-Gutiérrez L.   +3 more
europepmc   +1 more source

Echoes of the Past: The Intriguing Link between Chagas Disease and Insulin. [PDF]

Arq Bras Cardiol
Noya-Rabelo MM, Souza O.
europepmc   +1 more source

Peritoneal dialysis influences microRNA expression and pro-inflammatory response: results from a cross-sectional study. [PDF]

J Bras Nefrol
Costa NA, Pereira AG, Rodrigues HCN, Cuppari L, Felix TF, Minutentag IW, Reis PP, Balbi AL, Polegato BF, Azevedo PS, Zornoff LAM, Paiva SAR, Ponce D, Rogero MM, Minicucci MF.   +14 more
europepmc   +1 more source

KIM-1 as a biomarker of kidney tubular damage in normoalbuminuric patients with type 2 diabetes mellitus and insulin resistance. [PDF]

J Bras Nefrol
Oliveira LE, Paniz C, Moresco RN, Carvalho JAM.   +3 more
europepmc   +1 more source

[Side effects and pharmacovigilance of GLP1 agonists]. [PDF]

Aten Primaria
Maria Tablado MA.
europepmc   +1 more source

Position Statement on Cardiometabolic Health Across the Woman's Life Course - 2025. [PDF]

Arq Bras Cardiol
Oliveira GMM, Almeida MCC, Valério CM, Giuffrida F, Espíndola Neto L, Izar MCO, Marques-Santos C, Freire CMV, Albuquerque CJDM, Chagas ACP, Précoma DB, Mesquita ET, Saraiva JFK, Costa MENC, Lemke VMG, Lucena AJG, Brandão AA, Paiva Fagundes Junior AA, Macedo AVS, Polanczyk CA, Leitão CB, Silveira DS, Coutinho EDR, Nahas EAP, Alexandre ERG, Campana EMG, Bragança EOV, Colombo FMC, Barbosa ICQ, Rivera IR, Kulak Junior J, Salles JEN, Sá JR, Soares Júnior JM, Dourado LA, Moura LZ, Magalhães LBNC, Pompei LM, Passaglia LG, Assad MHV, Rodrigues MAH, Rivera MAM, Lopes MAAAM, Paiva MSMO, Castro ML, Campos MDSB, Souza OF, Medeiros OO, Freitas RAP, Carvalho RCM, Silva SCTFD, Rodrigues TCV, Avila WS, Silva Júnior WSD, Nazima WI, Costa-Paiva LHSD, Wender MCO.   +56 more
europepmc   +2 more sources